Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rose essence versus metoclopramide for nausea and vomiting in pregnancy
IRCT20170628034792N4Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of metoclopramide in nausea and vomiting of pregnancy (NVP) (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: nausea and vomiting. Started Jul 2017; status: completed.
02
Drugs
metoclopramide
03
Conditions
nausea and vomiting of pregnancy (NVP)
Beyond the preview
Go deeper on IRCT20170628034792N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170628034792N4.